Revance Therapeutics Inc (RVNC)

[IanFromSI]

Even at the current low price, the market cap is still in excess of $1.1 billion.

For the foreseeable future the feds will be taking the excess liquidity out of the system and raising interest rates.

The Allergan organization is not well known for giving away market share without a massive fight. The last competitor that came up against them, was able to give away their product for free, but once they started charging, the sales disappeared.

Without sufficient revenue to support its current price, RVNC could continue to drift lower for many more months. … and there’s nothing imminent to offset the feds continued tightening.

Nevertheless, good luck.
Surely, Foley won’t fail again.